1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Roche Holding AG
  6. News
  7. Summary
    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

ROCHE HOLDINGS AG : Buy rating from Deutsche Bank

01/17/2022 | 07:31am EDT

In a research note published by Emmanuel Papadakis, Deutsche Bank advises its customers to buy the stock. The target price continues to be set at CHF 425.


ę MarketScreener with dpa-AFX Analyser 2022
All news about ROCHE HOLDING AG
05/18Judgement On The First Drug Patent Linkage Lawsuit In China Is Issued
AQ
05/17AlphaValue/Baader Europe Lifts Price Target on Roche, Maintains Add Recommendation
MT
05/16TRANSCRIPT : Roche Holding AG - Special Call
CI
05/13PUMP / DUMP #31 : The week's gainers and losers
05/13ROCHE HOLDINGS AG : Reduced to Neutral by Jefferies
MD
05/12Roche believes cancer drug setback not a fatal blow to growth prospects
RE
05/12ROCHE HOLDINGS AG : Gets a Neutral rating from Morgan Stanley
MD
05/12ROCHE HOLDINGS AG : Deutsche Bank lowers his opinion and switches to Neutral
MD
05/12Roche Teams Up With Global Fund To Boost Diagnostic Systems In Low, Middle-income Natio..
MT
05/12Roche enters partnership with the Global Fund to support low- and middle-income countri..
GL
More news
Analyst Recommendations on ROCHE HOLDING AG
More recommendations
Financials
Sales 2022 64 123 M 64 891 M 64 891 M
Net income 2022 14 877 M 15 055 M 15 055 M
Net Debt 2022 10 808 M 10 937 M 10 937 M
P/E ratio 2022 17,3x
Yield 2022 3,02%
Capitalization 261 B 264 B 264 B
EV / Sales 2022 4,24x
EV / Sales 2023 4,07x
Nbr of Employees 100 920
Free-Float 82,4%
Chart ROCHE HOLDING AG
Duration : Period :
Roche Holding AG Technical Analysis Chart | ROG | CH0012032048 | MarketScreener
Technical analysis trends ROCHE HOLDING AG
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 321,25 CHF
Average target price 394,40 CHF
Spread / Average Target 22,8%
EPS Revisions
Managers and Directors
Severin Schwan Chief Executive Officer & Executive Director
Alan Hippe Chief Financial & Information Officer
Christoph Franz Chairman
Levi A. Garraway Chief Medical Officer
Pascale Schmidt Chief Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
ROCHE HOLDING AG-15.26%264 329
JOHNSON & JOHNSON2.59%461 811
PFIZER, INC.-14.65%282 789
ABBVIE INC.12.58%269 361
ELI LILLY AND COMPANY6.87%265 718
NOVO NORDISK A/S1.07%238 091